The benefit of individualized low-dose hCG support for high responders in GnRHa-triggered IVF/ICSI cycles

Journal of the Chinese Medical Association

Volumn 79, Issue 7, 2016, Pages 387-393

  Huang, Chen Yu ^a,b   Shieh, Miawh Lirng ^a   Li, Hsin Yang ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

agonist trigger; high responders; human chorionic gonadotropin (hCG); in vitro fertilization (IVF); ovarian hyperstimulation syndrome (OHSS)

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL; ESTRADIOL VALERATE; FOLLITROPIN; GONADORELIN AGONIST; LEUPRORELIN; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN; TRIPTORELIN; GONADORELIN;

ADULT; ARTICLE; DRUG DOSE REDUCTION; EMBRYO; ESTRADIOL BLOOD LEVEL; FEMALE; HUMAN; IN VITRO FERTILIZATION; INTRACYTOPLASMIC SPERM INJECTION; LOW DRUG DOSE; LUTEAL PHASE; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OVARY HYPERSTIMULATION; PERSONALIZED MEDICINE; PREGNANCY OUTCOME; PREGNANCY RATE; RETROSPECTIVE STUDY; TAIWAN; TERTIARY HEALTH CARE; AGONISTS; BLOOD; OVARIAN HYPERSTIMULATION SYNDROME; PREGNANCY; PROCEDURES;

ADULT; CHORIONIC GONADOTROPIN; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; OVARIAN HYPERSTIMULATION SYNDROME; PREGNANCY; PREGNANCY RATE; PROGESTERONE; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 84964597661     PISSN: 17264901     EISSN: 17287731     Source Type: Journal    
DOI: 10.1016/j.jcma.2016.02.006     Document Type: Article

References (30)

1. 1 Humaidan, P., Quartarolo, J., Papanikolaou, E.G., Preventing ovarian hyperstimulation syndrome: guidance for the clinician. Fertil Steril 94 (2010), 389–400.
2. 2 Damewood, M.D., Shen, W., Zacur, H.A., Schlaff, W.D., Rock, J.A., Wallach, E.E., Disappearance of exogenously administered human chorionic gonadotropin. Fertil Steril 52 (1989), 398–400.
3. 3 Nakano, R., Mizuno, T., Kotsuji, F., Katayama, K., Wshio, M., Tojo, S., ‘Triggering’ of ovulation after infusion of synthetic luteinizing hormone releasing factor (LRF). Acta Obstet Gynecol Scand 52 (1973), 269–272.
4. 4 Gonen, Y., Balakier, H., Powell, W., Casper, R.F., Use of gonadotropin-releasing hormone agonist to trigger follicular maturation for in vitro fertilization. J Clin Endocrinol Metab 71 (1990), 918–922.
5. 5 Itskovitz, J., Boldes, R., Levron, J., Erlik, Y., Kahana, L., Brandes, J.M., Induction of preovulatory luteinizing hormone surge and prevention of ovarian hyperstimulation syndrome by gonadotropin-releasing hormone agonist. Fertil Steril 56 (1991), 213–220.
6. 6 Humaidan, P., Bredkjær, H.E., Bungum, L., Bungum, M., Grøndahl, M.L., Westergaard, L.G., et al. GnRH agonist (Buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomised study. Hum Reprod 20 (2005), 1213–1220.
7. 7 Hoff, J.D., Quigley, M.E., Yen, S.S., Hormonal dynamics at midcycle: a revaluation. J Clin Endocrinol Metab 57 (1983), 792–796.
8. 8 Youssef, M.A., Van der Veen, F., Al-Inany, H.G., Griesinger, G., Mochtar, M.H., Aboulfoutouh, I., et al. Gonadotropin-releasing hormone agonist vs. HCG for oocyte triggering in antagonist assisted reproductive technology cycles. Cochrane Database Syst Rev, 19, 2011 CD008046.
9. 9 Griesinger, G., Diedrich, K., Devroey, P., Kolibianakis, E.M., GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systemic review and meta-analysis. Hum Reprod Update 12 (2006), 159–168.
10. 10 Fauser, B.C., de Jong, D., Olivennes, F., Wramsby, H., Tay, C., Itskovitz-Eldor, J., et al. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J Clin Endocrinol Metab 87 (2002), 709–715.
11. 11 Nevo, O., Eldar-Geva, T., Kol, S., Itskovitz-Eldor, J., Lower levels of inhibin A and pro-alphaC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist vs. human chorionic gonadotropin. Fertil Steril 79 (2003), 1123–1128.
12. 12 Engmann, L., DiLuigi, A., Schmidt, D., Nulsen, J., Maier, D., Benadiva, C., The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril 89 (2008), 84–91.
13. 13 Shapiro, B.S., Daneshmand, S.T., Garner, F.C., Aguirre, M., Thomas, S., Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization. Fertil Steril 90 (2008), 231–233.
14. 14 Humaidan, P., Bredkjær, H.E., Westergaard, L.G., Andersen, C.Y., 1,500 IU human chorionic gonadotropin administered at oocyte retrieval rescues the luteal phase when gonadotropin-releasing hormone agonist is used for ovulation induction: a prospective, randomized, controlled study. Fertil Steril 93 (2010), 847–854.
15. 15 Veeck, L.L., An atlas of human gametes and conceptuses. 1999, Parthenon, New York, 40–45.
16. 16 Golan, A., Ron-el, R., Herman, A., Soffer, Y., Weinraub, Z., Caspi, E., Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv 44 (1989), 430–440.
17. 17 Kol, S., Luteolysis induced by a gonadotropin-releasing hormone agonist is the key to prevention of ovarian hyperstimulation syndrome. Fertil Steril 81 (2004), 1–5.
18. 18 Humaidan, P., Kol, S., Papanikolaou, E.G., GnRH agonist for triggering of final oocyte maturation: time for a change of practice?. Hum Reprod Update 17 (2011), 510–524.
19. 19 Humaidan, P., Luteal phase rescue in high-risk OHSS patients by GnRHa triggering in combination with low-dose HCG: a pilot study. Reprod Biomed Online 18 (2009), 630–634.
20. 20 Shapiro, B.S., Daneshmand, S.T., Garner, F.C., Aguirre, M., Hudson, C., Comparison of ‘‘triggers’’ using leuprolide acetate alone or in combination with low-dose human chorionic gonadotropin. Fertil Steril 95 (2011), 2715–2717.
21. 21 Radesic, B., Tremellen, K., Oocyte maturation employing a GnRH agonist in combination with low dose hCG luteal rescue minimises the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates. Hum Reprod 26 (2011), 3437–3442.
22. 22 Acevedo, B., Gomez-Palomares, J.L., Ricciarelli, E., Hernandez, E.R., Triggering ovulation with gonadotropin-releasing hormone agonists does not compromise embryo implantation rates. Fertil Steril 86 (2006), 1682–1687.
23. 23 Griffin, D., Benadiva, C., Kummer, N., Budinetz, T., Nulsen, J., Engmann, L., Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders. Fertil Steril 97 (2012), 1316–1320.
24. 24 Erb, T.M., Vitek, W., Wakim, A.N., Gonadotropin-releasing hormone agonist or human chorionic gonadotropin for final oocyte maturation in an oocyte donor program. Fertil Steril 93 (2010), 374–378.
25. 25 Joo, B.S., Park, S.H., An, B.M., Kim, K.S., Moon, S.E., Moon, H.S., Serum estradiol levels during controlled ovarian hyperstimulation influence the pregnancy outcome of in vitro fertilization in a concentration-dependent manner. Fertil Steril 93 (2010), 442–446.
26. 26 Liu, Y., Kodithuwakku, S.P., Ng, P.Y., Chai, J., Ng, E.H., Yeung, W.S., et al. Excessive ovarian stimulation up-regulates the Wnt-signaling molecule DKK1 in human endometrium and may affect implantation: an in vitro co-culture study. Hum Reprod 25 (2010), 479–490.
27. 27 Kolibianakis, E.M., Griesinger, G., Venetis, C.A., GnRH agonist for triggering final oocyte maturation: time for a critical evaluation of data. Hum Reprod Update 18 (2012), 228–229.
28. 28 Humaidan, P., Bungum, L., Bungum, M., Andersen, C.Y., Rescue of corpus luteum function with peri-ovulatory hCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study. Reprod Biomed Online 13 (2006), 173–178.
29. 29 Humaidan, P., Agonist trigger: what is the best approach? Agonist trigger and low dose hCG. Fertil Steril 97 (2012), 529–530.
30. 30 Kol, S., Humaidan, P., Itskovitz-Eldor, J., GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study. Hum Reprod 26 (2011), 2874–2877.